Stock Movers Moderna Rises, Abercrombie & Finch Drops, and Brown-Forman Gains on Better Than Feared Guidance
Mar 4, 2026
A biotech settlement clears a major legal overhang and sends shares higher. A clothing retailer slips after sales and profit forecasts miss expectations and tariffs weigh on performance. A spirits maker posts better-than-expected quarterly results but warns of a challenging consumer backdrop and volatile market visibility.
AI Snips
Chapters
Transcript
Episode notes
Moderna Settlement Removes Big Legal Overhang
- Moderna removed a major financial overhang by agreeing to pay $950 million to settle delivery-technology litigation.
- Carmen Reineke notes the settlement ends worldwide disputes with Arbutus and Genevant and helped spark an 86% year-to-date rally.
Abercrombie Hits Tariff And Hollister Headwinds
- Abercrombie & Fitch missed Q4 comparable sales and lowered Q1 net sales and profit forecasts below consensus.
- Carmen highlights Hollister's weaker growth and a 15 percent tariff headwind expected to persist into fiscal 2026.
Company Incorporates 15 Percent Tariff Into Guidance
- The company sees a small sales hit from the Middle East conflict and counts a 15 percent tariff into guidance with no expected refunds.
- Carmen notes the tariff story has been an ongoing overhang on the name.